BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

March 28, 2022

View Archived Issues

Identification of sites of metabolic liability for KRM-II-81 and evaluation of a deuterated analogue

Read More

Variant in the CTR1 gene causes novel disorder of copper metabolism

Read More

MK-6158: sGC stimulator clinical candidate for pulmonary arterial hypertension

Read More

Novel nonhallucinogenic DMT analogues as drug candidates for mental health and addiction disorders

Read More

Phosphatidylserine is crucial for synaptic pruning in adult-born neurons

Read More

New antibacterials identified at Roche

Read More

Yale University divulges new oligosaccharyltransferase complex inhibitors

Read More

HDAC inhibitors disovered at Chong Kun Dang Pharmaceutical

Read More

Dompe Farmaceutici describes new peptides with angiogenic activity

Read More

Bayer patents P2X purinoceptor 4 antagonists

Read More

Novel USP30 inhibitors as potential anti-Parkinson candidates

Read More

Novartis details discovery, preclinical data of novel antimalarial compound INE-963

Read More

Sosei Heptares' GLP-1/2 agonist HTL-0030023 shows promising results for treating NAFLD and NASH

Read More

Missense variants in DDX39B linked to novel syndrome of global neurodevelopmental delay

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 12, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing